… Epidermal growth factor receptor (EGFR) is a vital intermediate in cell signaling pathway …
Here, we have discussed anti-cancer activity and growth factor receptor inhibitory activity …

… Schematic representation of dermatologic adverse events associated with fibroblast growth
factor receptor inhibition. Suggested dose modifications for dermatologic adverse events: …

Fibroblast growth factor receptors (FGFRs) are a family of receptor tyrosine kinases
expressed on the cell membrane that play crucial roles in both developmental and adult cells. …

… , a fibroblast growth factor receptor 1–3 kinase inhibitor, in … genetic alterations in fibroblast
growth factor receptors: results of a … , an inhibitor of fibroblast growth factor receptor (FGFR), in …

… , and the benefits of FGFR inhibitors have been demonstrated in … the clinical experience
with FGFR inhibitors to date, and … FGFR inhibitors in combination regimens with other agents. …

… inhibitors. The second and third generation EGFR inhibitors are referred to as irreversible
inhibitors (… of quinazoline-based kinase inhibitors for mutant epidermal growth factor receptors. …

The identification of molecular agents inhibiting specific functions in cancer cells progression
is considered as one of the most successful plans in cancer treatment. The epidermal …

… growth factor receptor (EGFR) belongs to the ERBB family of tyrosine kinase receptors. EGFR
… interaction, and the progress in the development of EGFR inhibitors have been explored. …

SARS-CoV-2 infections are rapidly spreading around the globe. The rapid development of
therapies is of major importance. However, our lack of understanding of the molecular …

… growth factors such as PLGF, EGF, cytokines, etc. [58]. Upregulation and activation of growth
factor receptors … This activated receptor leads to endothelial cell sprouting, increase in the …